市場調查報告書

全球制吐劑市場

Antiemetic Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 893729
出版日期 內容資訊 英文 94 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球制吐劑市場 Antiemetic Drugs
出版日期: 2019年07月01日內容資訊: 英文 94 Pages
簡介

本報告提供全球制吐劑市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 調查方法

第2章 摘要整理

  • 市場概要
    • 全球競爭企業的市場佔有率
    • 全球市場佔有率方案
  • 主要參與企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲各國
  • 亞太地區
  • 其他各國

第4章 競爭

  • ABBOTT LABORATORIES
  • Astellas Pharma Inc.株式會社
  • BAXTER INTERNATIONAL
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS AG
  • PFIZER
  • SANOFI-AVENTIS US
  • BAXTER INTERNATIONAL
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS AG
  • PFIZER
  • SANOFI-AVENTIS US

第5章 相關調查

目錄
Product Code: MCP10304

Antiemetic Drugs market worldwide is projected to grow by US$2.2 Billion, driven by a compounded growth of 6.2%. Chemotherapy, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.8%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Chemotherapy will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 7.1% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$101.2 Million to the region's size and clout in the next 5 to 6 years. Over US$325.9 Million worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Chemotherapy will reach a market size of US$258.1 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 6% over the next couple of years and add approximately US$381.2 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include among others, Abbott Laboratories, Inc. (USA); Astellas Pharma, Inc. (Japan); Baxter International, Inc. (USA); Cipla Ltd. (India); GlaxoSmithKline PLC (United Kingdom); Johnson & Johnson (USA); Merck & Co., Inc. (USA); Novartis AG (Switzerland); Pfizer, Inc. (USA); Sanofi-aventis U.S. LLC (USA)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Antiemetic Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Antiemetic Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Antiemetic Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Antiemetic Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Chemotherapy (Application) Global Opportunity Assessment in US$ Million by Region/Country: 2018-2025
  • TABLE 5: Chemotherapy (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 6: Chemotherapy (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Gastroenteritis (Application) Worldwide Sales in US$ Million by Region/Country: 2018-2025
  • TABLE 8: Gastroenteritis (Application) Historic Demand Patterns in US$ Million by Region/Country: 2009-2017
  • TABLE 9: Gastroenteritis (Application) Market Share Shift across Key Geographies: 2009 VS 2019 VS 2025
  • TABLE 10: Surgery (Application) Global Market Estimates & Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 11: Surgery (Application) Retrospective Demand Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 12: Surgery (Application) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Other Applications (Application) Demand Potential Worldwide in US$ Million by Region/Country: 2018-2025
  • TABLE 14: Other Applications (Application) Historic Sales Analysis in US$ Million by Region/Country: 2009-2017
  • TABLE 15: Other Applications (Application) Share Breakdown Review by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Antiemetic Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 16: United States Antiemetic Drugs Latent Demand Forecasts in US$ Million by Application: 2018 to 2025
    • TABLE 17: Antiemetic Drugs Historic Demand Patterns in the United States by Application in US$ Million for 2009-2017
    • TABLE 18: Antiemetic Drugs Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 19: Canadian Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 20: Antiemetic Drugs Market in Canada: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 21: Canadian Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • JAPAN
    • TABLE 22: Japanese Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
    • TABLE 23: Japanese Antiemetic Drugs Market in US$ Million by Application: 2009-2017
    • TABLE 24: Antiemetic Drugs Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 25: Chinese Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
    • TABLE 26: Antiemetic Drugs Market Review in China in US$ Million by Application: 2009-2017
    • TABLE 27: Chinese Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • EUROPE
    • Market Facts & Figures
    • European Antiemetic Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 28: European Antiemetic Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 29: Antiemetic Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 30: European Antiemetic Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 31: European Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 32: Antiemetic Drugs Market in Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 33: European Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 34: Antiemetic Drugs Quantitative Demand Analysis in France in US$ Million by Application: 2018-2025
    • TABLE 35: French Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 36: French Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • GERMANY
    • TABLE 37: Antiemetic Drugs Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by Application for the Period 2018-2025
    • TABLE 38: German Antiemetic Drugs Market in Retrospect in US$ Million by Application: 2009-2017
    • TABLE 39: Antiemetic Drugs Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 40: Italian Demand for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
    • TABLE 41: Antiemetic Drugs Market Review in Italy in US$ Million by Application: 2009-2017
    • TABLE 42: Italian Antiemetic Drugs Market Share Breakdown by Application: 2009 VS 2019 VS 2025
  • UNITED KINGDOM
    • TABLE 43: United Kingdom Demand Estimates and Forecasts for Antiemetic Drugs in US$ Million by Application: 2018 to 2025
    • TABLE 44: United Kingdom Antiemetic Drugs Market in US$ Million by Application: 2009-2017
    • TABLE 45: Antiemetic Drugs Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 46: Rest of Europe Antiemetic Drugs Addressable Market Opportunity in US$ Million by Application: 2018-2025
    • TABLE 47: Antiemetic Drugs Market in Rest of Europe: Summarization of Historic Demand in US$ Million by Application for the Period 2009-2017
    • TABLE 48: Rest of Europe Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 49: Antiemetic Drugs Quantitative Demand Analysis in Asia-Pacific in US$ Million by Application: 2018-2025
    • TABLE 50: Asia-Pacific Antiemetic Drugs Historic Market Review in US$ Million by Application: 2009-2017
    • TABLE 51: Asia-Pacific Antiemetic Drugs Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025
  • REST OF WORLD
    • TABLE 52: Rest of World Antiemetic Drugs Market Quantitative Demand Analysis in US$ Million by Application: 2018 to 2025
    • TABLE 53: Antiemetic Drugs Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by Application for 2009-2017
    • TABLE 54: Rest of World Antiemetic Drugs Market Share Analysis by Application: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • ASTELLAS PHARMA
  • BAXTER INTERNATIONAL
  • CIPLA
  • GLAXOSMITHKLINE PLC
  • JOHNSON & JOHNSON
  • MERCK & CO., INC.
  • NOVARTIS AG
  • PFIZER
  • SANOFI-AVENTIS US

V. CURATED RESEARCH

Back to Top